NCT03019939View on ClinicalTrials.gov

Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

August 10, 2020

Study Completion Date

August 10, 2020

Conditions
Acute Myeloid LeukemiaMyelodysplastic SyndromeNeutropenia
Interventions
DRUG

Isavuconazole

Given PO or IV

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03019939 - Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia | Biotech Hunter | Biotech Hunter